Molecular Diagnostics to Grow at 9% by 2017

Rise in biomarkers for chronic diseases along with rapid technological advancements will drive the market at immense pace, says RNCOS.

NOIDA, India (prHWY.com) March 11, 2013 - As per the new research report by RNCOS, "In-Vitro Diagnostics Market Analysis to 2017", the global molecular diagnostics market is growing at a rapid pace and poised to grow significantly at a CAGR of around 9% during 2012-2017. Key factors set to drive growth within the molecular diagnostics market include advances in functional genomics, bioinformatics, and next-generation sequencing technologies.

The report provides a thorough analysis of key IVD markets across the globe to highlight regions with the highest potential for growth. Besides, the report has delved into the business dynamics of the major players of the market. To provide a thorough understanding of the Company's business model, the current and historical financials of the Company have been analyzed. Moreover, each Company's strengths and weaknesses along with their recent industrial activities have also been assessed. This will help the reader to gain a deeper insight into the current competitive landscape and position its company accordingly.

The study also includes a rational analysis of the current status and expected position of the market by 2017. It facilitates the future forecasts on the total IVD market, clinical segments and regional markets. The analysis of the emerging sectors and key players in the market provides a holistic view to the reader. Explaining some of the constraints faced by the industry, the study also covers the emerging trends which would have a positive impact on the market growth. Overall, the report contains key actionable insights that will help the reader to gain a deeper knowledge of the industry, identify key opportunities and design suitable business strategies.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM472.htm

Some of our Related Reports are:

- US Telelaparoscopy Opportunity Analysis (http://www.rncos.com/Report/IM469.htm)
- US Proton Therapy Market Analysis to 2017 (http://www.rncos.com/Report/IM465.htm)
- US Personalized Cancer Genome Sequencing Market (http://www.rncos.com/Report/IM453.htm)
- Brazil Healthcare - New Opportunities for Growth (http://www.rncos.com/Report/IM451.htm)
- US Non-Invasive Prenatal Diagnostics - Market Insight (http://www.rncos.com/Report/IM450.htm)

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

About RNCOS

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.

###

Tag Words: immunochemistry market

Categories: Health

Press Release Contact
B-129, Sector 6 Noida - 201301
91-120-4224-700
91-120-4224-707

Link To This Press Release:

URL HTML Code